A systemic toxicity index developed to assess peripheral changes in mood episodes

Oxidative stress markers in bipolar disorder: A meta-analysis

Andreazza, A. C., Kauer-Sant'Anna, M., Frey, B. N., Bond, D. J., Kapczinski, F., Young, L. T., & Yatham, L. N. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.04.013 · Cited by 526 · see citing works

The Increasing Medical Burden in Bipolar Disorder

Kupfer, D. J. (2005) · JAMA · doi:10.1001/jama.293.20.2528 · Cited by 489 · see citing works

Allostatic load in bipolar disorder: Implications for pathophysiology and treatment

Kapczinski, F. P., Vieta, E., Andreazza, A. C., Frey, B. N., Gomes, F. A., Tramontina, J., Kauer‐Sant’Anna, M., Grassi‐Oliveira, R., & Post, R. M. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.10.005 · Cited by 479 · see citing works

Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder

Kauer‐Sant’Anna, M., Kapczinski, F. P., Andreazza, A. C., Bond, D. J., Lam, R. W. M., Young, L. T., & Yatham, L. N. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009310 · Cited by 434 · see citing works

Severe Mental Illness and Risk of Cardiovascular Disease

Newcomer, J. W., & Hennekens, C. H. (2007) · JAMA · doi:10.1001/jama.298.15.1794 · Cited by 433 · see citing works

Biomarkers in psychiatry

Singh, I., & Rose, N. (2009) · Nature · doi:10.1038/460202a · Cited by 389 · see citing works

Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena

Post, R. M. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.04.003 · Cited by 303 · see citing works

Optimization and validation of an alternative method to evaluate total reactive antioxidant potential

Dresch, M. T. K., Rossato, S. B., Kappel, V. D., Biegelmeyer, R., Hoff, M. L. M., Mayorga, P., Zuanazzi, J. Â. S., Henriques, A. T., & Moreira, J. C. F. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.10.036 · Cited by 94 · see citing works

Early intervention in bipolar disorders: Clinical, biochemical and neuroimaging imperatives

Berk, M., Malhi, G. S., Hallam, K. T., Gama, C. S., Dodd, S., Andreazza, A. C., Frey, B. N., & Kapczinski, F. P. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.08.011 · Cited by 80 · see citing works

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178 · see citing works

Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis

Munkholm, K., Braüner, J. V., Kessing, L. V., & Vinberg, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.018 · Cited by 402 · see citing works

Cytokines in bipolar disorder: A systematic review and meta-analysis

Munkholm, K., Vinberg, M., & Vedel Kessing, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.010 · Cited by 256 · see citing works

Peripheral biomarkers and illness activity in bipolar disorder

Kapczinski, F. P., Dal‐Pizzol, F., Teixeira, A. L., Magalhães, P. V. D. S., Kauer‐Sant’Anna, M., Klamt, F., Moreira, J. C. F., Pasquali, M. A. D. B., Fries, G. R., Quevedo, J., et al. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.05.015 · Cited by 236 · see citing works

Staging systems in bipolar disorder: an <scp>I</scp>nternational <scp>S</scp>ociety for <scp>B</scp>ipolar <scp>D</scp>isorders <scp>T</scp>ask <scp>F</scp>orce <scp>R</scp>eport

Kapczinski, F., Magalhães, P. V. S., Balanzá‐Martinez, V., Dias, V. V., Frangou, S., Gama, C. S., Gonzalez‐Pinto, A., Grande, I., Ha, K., Kauer‐Sant'Anna, M., et al. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12305 · Cited by 217 · see citing works

Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder

Behr, G. A., Moreira, J. C. F., & Frey, B. N. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/609421 · Cited by 205 · see citing works

Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance

Kunz, M., Ceresér, K. M. M., Goi, P. D., Fries, G. R., Teixeira, A. L., Fernandes, B. S., Belmonte-de-Abreu, P. S., Kauer‐Sant’Anna, M., Kapczinski, F. P., & Gama, C. S. (2011) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462011000300010 · Cited by 189 · see citing works

Is bipolar disorder an inflammatory condition? The relevance of microglial activation

Stertz, L., Magalhães, P. V. D. S., & Kapczinski, F. P. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835aa4b4 · Cited by 182 · see citing works

Circulating Levels of Brain-Derived Neurotrophic Factor: Correlation with mood, Cognition and Motor Function

Teixeira, A. L., Barbosa, I. G., Diniz, B. S., & Kümmer, A. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.111 · Cited by 162 · see citing works

The Role of BDNF as a Mediator of Neuroplasticity in Bipolar Disorder

Grande, I., Fries, G. R., Kunz, M., & Kapczinski, F. P. (2010) · Psychiatry Investigation · doi:10.4306/pi.2010.7.4.243 · Cited by 161 · see citing works

Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis

Munkholm, K., Vinberg, M., & Kessing, L. V. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.54 · Cited by 157 · see citing works

Medical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems

SayuriYamagata, A., Brietzke, E. M., Rosenblat, J. D., Kakar, R., & McIntyre, R. S. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.12.059 · Cited by 153 · see citing works

The Clinical Implications Of Cognitive Impairment and Allostatic Load in Bipolar Disorder

Vieta, E., Popović, D., Rosa, A. R., Solé, B., Grande, I., Frey, B. N., Martínez‐Arán, A., Sánchez‐Moreno, J., Balanzá‐Martínez, V., Tabarés‐Seisdedos, R., et al. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.11.007 · Cited by 147 · see citing works

Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity

Pedrini, M., Massuda, R., Fries, G. R., Pasquali, M. A. D. B., Schnorr, C. E., Moreira, J. C. F., Teixeira, A. L., Lobato, M. I. R., Walz, J. C., Belmonte-de-Abreu, P. S., et al. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.03.019 · Cited by 142 · see citing works

The Immunology of Bipolar Disorder

Barbosa, I. G., Machado‐Vieira, R., Soares, J. C., & Teixeira, A. L. (2014) · NeuroImmunoModulation · doi:10.1159/000356539 · Cited by 140 · see citing works

The load of short telomeres is increased and associated with lifetime number of depressive episodes in bipolar II disorder

Elvsåshagen, T., Vera, E., Bøen, E., Bratlie, J., Andreassen, O. A., Josefsen, D., Malt, U. F., Blasco, M. A., & Boye, B. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.006 · Cited by 133 · see citing works

Neuroprogression and illness trajectories in bipolar disorder

Kapczinski, N. S., Mwangi, B., Cassidy, R. M., Librenza‐Garcia, D., Bermúdez, M. B., Kauer‐Sant’Anna, M., Kapczinski, F. P., & Passos, I. C. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1240615 · Cited by 125 · see citing works

Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compass

Davis, J., Maes, M., Andreazza, A., McGrath, J. J., Tye, S. J., & Berk, M. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.139 · Cited by 123 · see citing works

Towards a clinical staging for bipolar disorder: Defining patient subtypes based on functional outcome

Reinares, M., Papachristou, E., Harvey, P. D., Bonnín, C. D. M., Sánchez‐Moreno, J., Torrent, C., Ayuso‐Mateos, J. L., Ploubidis, G. B., Vieta, E., & Frangou, S. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.005 · Cited by 124 · see citing works

Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers

Barbosa, I. G., Rocha, N. P., Huguet, R. B., Ferreira, R. A., Salgado, J. V., de Carvalho, L. A., Pariante, C. M., & Teixeira, A. L. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.034 · Cited by 121 · see citing works

Excessive and Premature New-Onset Cardiovascular Disease Among Adults With Bipolar Disorder in the US NESARC Cohort

Goldstein, B. I., Schaffer, A., Wang, S., & Blanco, C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09300 · Cited by 120 · see citing works

Mediators of allostasis and systemic toxicity in bipolar disorder.

Grande, I., Magalhães, P., Kunz, M., Vieta, E., & Kapczinski, F. (2012) · Physiology and Behavior · doi:10.1016/j.physbeh.2011.10.029 · Cited by 121 · see citing works

N-acetylcysteine for major depressive episodes in bipolar disorder

Magalhães, P. V. D. S., Dean, O. M., Bush, A. I., Copolov, D., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson‐Hunt, M., & Berk, M. (2011) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462011000400011 · Cited by 113 · see citing works

Staging and Neuroprogression in Bipolar Disorder: A Systematic Review of the Literature

Gama, C. S., Kunz, M., Magalhães, P. V. D. S., & Kapczinski, F. P. (2013) · Brazilian Journal of Psychiatry · doi:10.1016/j.rbp.2012.09.001 · Cited by 112 · see citing works

On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders: A systematic review

Pinto, J. V., Moulin, T. C., & Amaral, O. B. (2017) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.10.001 · Cited by 103 · see citing works

Therapeutic use of omega-3 fatty acids in bipolar disorder

Balanzá‐Martínez, V., Fries, G. R., Colpo, G. D., Silveira, P. P., Portella, A. K., Tabarés‐Seisdedos, R., & Kapczinski, F. P. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.42 · Cited by 104 · see citing works

N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial

Magalhães, P. V. D. S., Dean, O. M., Bush, A. I., Copolov, D., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson‐Hunt, M., & Berk, M. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.001 · Cited by 100 · see citing works

Cumulative morbidity and prognostic staging of illness in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

Magalhães, P. V. D. S., Dodd, S., Nierenberg, A. A., & Berk, M. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412460593 · Cited by 98 · see citing works

Preliminary Findings Regarding Proinflammatory Markers and Brain-Derived Neurotrophic Factor Among Adolescents with Bipolar Spectrum Disorders

Goldstein, B. I., Collinger, K. A., Lotrich, F. E., Marsland, A. L., Gill, M., Axelson, D., & Birmaher, B. B. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0009 · Cited by 97 · see citing works

Biomarkers for bipolar disorder: current status and challenges ahead

Teixeira, A. L., Colpo, G. D., Fries, G. R., Bauer, I. E., & Selvaraj, S. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1550361 · Cited by 95 · see citing works

Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder

Magalhães, P. V. D. S., Kapczinski, F. P., Nierenberg, A. A., Deckersbach, T., Weisinger, D., Dodd, S., & Berk, M. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01794.x · Cited by 93 · see citing works

The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment

Andreazza, A. C., & Young, L. T. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000096 · Cited by 80 · see citing works

Mitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder

Scaini, G., Andrews, T., Lima, C. N. D. C., Benevenuto, D., STRECK, E. L., & Quevedo, J. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.12.002 · Cited by 77 · see citing works

Staging Models in Bipolar Disorder: A Systematic Review of the Literature

Muneer, A. (2016) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2016.14.2.117 · Cited by 76 · see citing works

Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study

Magalhães, P. V. D. S., Jansen, K., Pinheiro, R. T., Colpo, G. D., da Motta, L. L., Klamt, F., da Silva, R. A., & Kapczinski, F. P. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001532 · Cited by 75 · see citing works

Differential biomarker signatures in unipolar and bipolar depression: A machine learning approach

Wollenhaupt-Aguiar, B., Librenza‐Garcia, D., Bristot, G., Przybylski, L., Stertz, L., Burque, R. K., Ceresér, K. M., Spanemberg, L., Caldieraro, M. A., Frey, B. N., et al. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419888027 · Cited by 68 · see citing works

Cumulative stress pathophysiology in schizophrenia as indexed by allostatic load

Nugent, K. L., Chiappelli, J., Rowland, L. M., & Hong, L. E. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.06.009 · Cited by 69 · see citing works

Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis

Berger, M., Juster, R., Westphal, S., Amminger, G. P., Bogerts, B., Schiltz, K., Bahn, S., Steiner, J. H., & Sarnyai, Z. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.02.001 · Cited by 74 · see citing works

Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder

Pfaffenseller, B., Fries, G. R., Wollenhaupt-Aguiar, B., Colpo, G. D., Stertz, L., Panizzutti, B., Magalhães, P. V., & Kapczinski, F. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811981 · Cited by 68 · see citing works

Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress–Induced Damage in Patients with Bipolar Disorder

Madireddy, S., & Madireddy, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031844 · Cited by 71 · see citing works

DNA Damage in Major Psychiatric Diseases

Raza, M. U., Tufan, T., Wang, Y., Hill, C. P., & Zhu, M. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9621-9 · Cited by 67 · see citing works

Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder

Pinto, J. V., Passos, I. C., Librenza‐Garcia, D., Marcon, G., Schneider, M. A., Conte, J. H., da Silva, J. P. A., Lima, L. P., Quincozes‐Santos, A., Kauer‐Sant’Anna, M., et al. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170828170921 · Cited by 61 · see citing works

Differential mitochondrial DNA copy number in three mood states of bipolar disorder

Wang, D., Li, Z., Liu, W., Zhou, J., Ma, X., Tang, J., & Chen, X. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1717-8 · Cited by 60 · see citing works

Neuroprogression as an illness trajectory in bipolar disorder: a selective review of the current literature

Serafini, G., Pardini, M., Monacelli, F., Orso, B., Girtler, N., Brugnolo, A., Amore, M., Nobili, F., & Team on Dementia of the IRCCS Ospedale Policlinico San Martino (2021) · Brain Sciences · doi:10.3390/brainsci11020276 · Cited by 56 · see citing works

Peripheral toxicity in crack cocaine use disorders

Narvaez, J. C. D. M., Magalhães, P. V. D. S., Fries, G. R., Colpo, G. D., Czepielewski, L. S., Vianna, P., Chies, J. A. B., Rosa, A. R., DIEMEN, L. V., Vieta, E., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.03.045 · Cited by 57 · see citing works

Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety

Molendijk, M. L., Bus, B. A. A., Spinhoven, P., Penninx, B. W. J. H., Prickaerts, J., Oude Voshaar, R. C., & Elzinga, B. M. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.587892 · Cited by 62 · see citing works

Oxidative stress and BDNF as possible markers for the severity of crack cocaine use in early withdrawal

Sordi, A. O., Pechansky, F., Kessler, F. H. P., Kapczinski, F. P., Pfaffenseller, B., Gubert, C., de Aguiar, B. W., Narvaez, J. C. D. M., Ornell, F. R., & DIEMEN, L. V. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3542-1 · Cited by 56 · see citing works

Damage‐associated molecular patterns and immune activation in bipolar disorder

Stertz, L., Fries, G. R., Rosa, A. R., Kauer‐Sant'anna, M., Ferrari, P., Paz, A. V. C., Green, C., Cunha, Â. B. M., Dal‐Pizzol, F., Gottfried, C., et al. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12417 · Cited by 53 · see citing works

Concepts of Neuroinflammation and Their Relationship With Impaired Mitochondrial Functions in Bipolar Disorder

Cyrino, L. A. R., de Lima, D. D., Ullmann, O. M., & Maia, T. P. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.609487 · Cited by 48 · see citing works

Refining and integrating schizophrenia pathophysiology – Relevance of the allostatic load concept

Misiak, B., Frydecka, D., Zawadzki, M., Krefft, M., & Kiejna, A. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.06.004 · Cited by 47 · see citing works

Interaction between BDNF rs6265 Met allele and low family cohesion is associated with smaller left hippocampal volume in pediatric bipolar disorder

Zeni, C., Mwangi, B., Cao, B., Hasan, K. M., Walss‐Bass, C., Zunta‐Soares, G. B., & Soares, J. C. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.09.031 · Cited by 46 · see citing works

Oxidative Stress in Older Patients with Bipolar Disorder

Andreazza, A. C., Gildengers, A. G., Rajji, T. K., Zuzarte, P., Mulsant, B. H., & Young, L. T. (2014) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.05.008 · Cited by 46 · see citing works

Update on bipolar disorder biomarker candidates

Teixeira, A. L., Salem, H., Frey, B. N., Barbosa, I. G., & Machado‐Vieira, R. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1248413 · Cited by 46 · see citing works

Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes

Fernandes, B. S., Gama, C. S., Walz, J. C., Ceresér, K. M. M., Fries, G. R., Colpo, G. D., de Aguiar, B. W., Pfaffenseller, B., Kauer‐Sant’Anna, M., & Kapczinski, F. P. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.11.020 · Cited by 44 · see citing works

Biomarkers and staging of bipolar disorder: a systematic review

Roda, Â., Chendo, I., & Kunz, M. (2014) · Trends in Psychiatry and Psychotherapy · doi:10.1590/2237-6089-2014-0002 · Cited by 43 · see citing works

State‐related alterations of gene expression in bipolar disorder: a systematic review

Munkholm, K., Vinberg, M., Berk, M., & Kessing, L. V. (2012) · Bipolar Disorders · doi:10.1111/bdi.12005 · Cited by 43 · see citing works

Novel biomarkers for bipolar disorder

Teixeira, A. L., Barbosa, I. G., Machado‐Vieira, R., Rizzo, L. B., Wieck, A., & Bauer, M. E. (2012) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2013.734807 · Cited by 41 · see citing works

Blood-based biomarkers predicting response to antidepressants

Busch, Y., & Menke, A. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1844-x · Cited by 36 · see citing works

Biological Pathways Associated with Neuroprogression in Bipolar Disorder

Wollenhaupt-Aguiar, B., Kapczinski, F. P., & Pfaffenseller, B. (2021) · Brain Sciences · doi:10.3390/brainsci11020228 · Cited by 36 · see citing works

Peripheral adenosine levels in euthymic patients with bipolar disorder

Gubert, C., Moritz, C. E. J., Vasconcelos-Moreno, M. P., Tietbohl-Santos, B., Sartori, J., Fijtman, A., Kauer‐Sant’Anna, M., Kapczinski, F. P., Battastini, A. M. O., & Magalhães, P. V. D. S. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.10.007 · Cited by 36 · see citing works

The effect of sunlight exposure on interleukin-6 levels in depressive and non-depressive subjects

Levandovski, R. M., Pfaffenseller, B., Carissimi, A., Gama, C. S., & Hidalgo, M. P. L. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-75 · Cited by 35 · see citing works

Peripheral Eotaxin-1 (CCL11) Levels and Mood Disorder Diagnosis in a Population-Based Sample of Young Adults

Magalhaes, P. V. S., Jansen, K., Stertz, L., Ferrari, P., Pinheiro, R. T., da Silva, R. A., & Kapczinski, F. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.10.007 · Cited by 33 · see citing works

Neuroimmune Biomarkers in Mental Illness

Herron, J. W., Nerurkar, L., & Cavanagh, J. (2018) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_45 · Cited by 34 · see citing works

Early apoptosis in peripheral blood mononuclear cells from patients with bipolar disorder

Fries, G. R., Vasconcelos-Moreno, M. P., Gubert, C., Tietbohl-Santos, B., da Rosa, A. L. S. T., Eisele, B. S., Sartori, J., Pfaffenseller, B., Kapczinski, F. P., & Kauer‐Sant’Anna, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.07.027 · Cited by 34 · see citing works

Challenges and developments in research of the early stages of bipolar disorder

Brietzke, E. M., Rosa, A. R., Pedrini, M., Noto, M. N., Kapczinski, F. P., & Scott, J. L. (2016) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2016-1975 · Cited by 31 · see citing works

Number of episodes in bipolar disorder: The case for more thoughtful conceptualization and measurement

Tremain, H., Fletcher, K., & Murray, G. (2019) · Bipolar Disorders · doi:10.1111/bdi.12872 · Cited by 30 · see citing works

Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder

Magalhães, P. V. D. S., Dean, O. M., Bush, A. I., Copolov, D., Weisinger, D., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson‐Hunt, M., et al. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.11.011 · Cited by 27 · see citing works

Reduced mRNA Expression of PTGDS in Peripheral Blood Mononuclear Cells of Rapid-Cycling Bipolar Disorder Patients Compared with Healthy Control Subjects

Munkholm, K., Peijs, L., Kessing, L. V., & Vinberg, M. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu101 · Cited by 28 · see citing works

Resolution of a manic episode treated with activated charcoal: Evidence for a brain–gut axis in bipolar disorder

Hamdani, N., Boukouaci, W., Hallouche, M. R., Charron, D. J., Krishnamoorthy, R., Leboyer, M., & Tamouza, R. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415595873 · Cited by 27 · see citing works

Val66Met polymorphism and serum brain‐derived neurotrophic factor in bipolar disorder: an open‐label trial

Grande, I., Magalhães, P. V. D. S., Chendo, I., Stertz, L., Fries, G. R., Ceresér, K. M. M., Cunha, A. B. M., Goi, P. D., Kunz, M., Udina, M., et al. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12192 · Cited by 26 · see citing works

A review on shared clinical and molecular mechanisms between bipolar disorder and frontotemporal dementia

Nascimento, C. F., Nunes, P. V., Rodriguez, R. D., Takada, L. T., Suemoto, C. K., Grinberg, L. T., Nitríni, R., & Lafer, B. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.04.008 · Cited by 26 · see citing works

Are remitted affective disorders and familial risk of affective disorders associated with metabolic syndrome, inflammation and oxidative stress? – a monozygotic twin study

Ottesen, N. M., Meluken, I., Frikke‐Schmidt, R., Plomgaard, P., Scheike, T., Fernandes, B. S., Berk, M., Poulsen, H. E., Kessing, L. V., Miskowiak, K. W., et al. (2019) · Psychological Medicine · doi:10.1017/s003329171900182x · Cited by 25 · see citing works

Association between the epigenetic lifespan predictor GrimAge and history of suicide attempt in bipolar disorder

Lima, C. N. D. C., Kovács, E. H. C., Mirza, S. A., Favero-Campbell, A. D., Díaz, A. P., Quevedo, J., Argue, B. M., Richards, J. G., Williams, A. J., Wemmie, J. A., et al. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01557-9 · Cited by 25 · see citing works

Differences in mitochondrial DNA copy number between patients with bipolar I and II disorders

Chung, J. K., Ahn, Y. M., Kim, S. A., & Joo, E.-J. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.11.016 · Cited by 23 · see citing works

Exploring the Evidence Implicating the Renin-Angiotensin System (RAS) in the Physiopathology of Mood Disorders

Mohite, S., Sanches, M., & Teixeira, A. L. (2019) · Protein and Peptide Letters · doi:10.2174/0929866527666191223144000 · Cited by 24 · see citing works

Potential Candidates for Biomarkers in Bipolar Disorder: A Proteomic Approach through Systems Biology

Ziani, P. R., Feiten, J. G., Goularte, J. F., Colombo, R., Antqueviezc, B., Géa, L. P., & Rosa, A. R. (2022) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2022.20.2.211 · Cited by 24 · see citing works

Dentate gyrus−cornu ammonis (CA) 4 volume is decreased and associated with depressive episodes and lipid peroxidation in bipolar II disorder: Longitudinal and cross‐sectional analyses

Elvsåshagen, T., Zuzarte, P., Westlye, L. T., Bøen, E., Josefsen, D., Boye, B., Hol, P. K., Malt, U. F., Young, L. T., & Andreazza, A. C. (2016) · Bipolar Disorders · doi:10.1111/bdi.12457 · Cited by 21 · see citing works

Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study

Berger, M., Lavoie, S., McGorry, P. D., Nelson, B., Markulev, C., Yuen, H. P., Schaefer, M. R., Sarnyai, Z., & Amminger, G. P. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.10.002 · Cited by 20 · see citing works

Treatment delay is associated with more episodes and more severe illness staging progression in patients with bipolar disorder

Goi, P. D., Vianna-Sulzbach, M., da Silveira, L. E., Grande, I., Chendo, I., Sodré, L. A., Ceresér, K. M. M., Rosa, A. R., Kunz, M., Kauer‐Sant’Anna, M., et al. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.04.004 · Cited by 19 · see citing works

Marcadores periféricos e a fisiopatologia do transtorno bipolar

Magalhães, P. V. D. S., Fries, G. R., & Kapczinski, F. P. (2012) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832012000200004 · Cited by 18 · see citing works

Systemic toxicity in early-stage mood disorders

Magalhães, P. V. D. S., Jansen, K., Pinheiro, R. T., Klamt, F., Teixeira, A. L., da Silva, R. A., & Kapczinski, F. P. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.05.008 · Cited by 18 · see citing works

Peripheral insulin-like growth factor 1 in bipolar disorder

da Silva, E. G., Pfaffenseller, B., Walz, J. C., Stertz, L., Fries, G. R., Rosa, A. R., & Magalhães, P. V. D. S. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.01.061 · Cited by 18 · see citing works

Agmatine as a potential therapeutic intervention in bipolar depression: the preclinical landscape

Watts, D., Pfaffenseller, B., Wollenhaupt-Aguiar, B., Géa, L. P., Cardoso, T. D. A., & Kapczinski, F. P. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1581764 · Cited by 16 · see citing works

N-acetylcysteine as a mitochondrial enhancer: a new class of psychoactive drugs?

Fries, G. R., & Kapczinski, F. P. (2011) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462011000400003 · Cited by 14 · see citing works

Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor

Brietzke, E. M., & Teixeira, A. L. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00822.x · Cited by 14 · see citing works

White matter volume is decreased in bipolar disorder at early and late stages

Duarte, J. Á., Massuda, R., Goi, P. D., Vianna-Sulzbach, M., Colombo, R., Kapczinski, F. P., & Gama, C. S. (2018) · Trends in Psychiatry and Psychotherapy · doi:10.1590/2237-6089-2017-0025 · Cited by 13 · see citing works

1H-MRS of hippocampus in patients after first manic episode

Gigante, A. D., Lafer, B., & Yatham, L. N. (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.819120 · Cited by 12 · see citing works

nflammation and damage-associated molecular patterns in major psychiatric disorders

Valiati, F. E., Feiten, J. G., Géa, L. P., Júnior, É. D. M. S., Scotton, E., Caldieraro, M. A., Salum, G. A., & Kauer‐Sant’Anna, M. (2022) · Trends in Psychiatry and Psychotherapy · doi:10.47626/2237-6089-2022-0576 · Cited by 11 · see citing works

Emotional memory in bipolar disorder: Impact of multiple episodes and childhood trauma

Fijtman, A., Bücker, J., Strange, B. A., Martins, D. S., Passos, I. C., Hasse-Sousa, M., Lima, F. M., Kapczinski, F. P., Yatham, L. N., & Kauer‐Sant’Anna, M. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.09.003 · Cited by 11 · see citing works

Immune Cell Ratios Are Higher in Bipolar Affective than Unipolar Depressive Disorder and Modulated by Mood Episode: A Retrospective, Cross-Sectional Study

Koureta, A., Asimakopoulos, L. O., Bozikas, V. P., & Agorastos, A. (2023) · Brain Sciences · doi:10.3390/brainsci13030448 · Cited by 12 · see citing works

The Staging of Major Mood Disorders: Clinical and Neurobiological Correlates

Muneer, A., & Mazommil, R. (2018) · Psychiatry Investigation · doi:10.30773/pi.2018.05.26 · Cited by 10 · see citing works

Association of pro-inflammatory cytokines with clinical features in euthymic patients with Bipolar-I-Disorder

Vares, E. A., Lehmann, S., Sauer, C., Pariante, C. M., Wieland, F., Soltmann, B., Bauer, M., & Ritter, P. S. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.07.125 · Cited by 10 · see citing works

Reduced Neurite Density in Neuronal Cell Cultures Exposed to Serum of Patients with Bipolar Disorder

Wollenhaupt-Aguiar, B., Pfaffenseller, B., Chagas, V. D. S., Castro, M. A. A., Passos, I. C., Kauer‐Sant’Anna, M., Kapczinski, F. P., & Klamt, F. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw051 · Cited by 10 · see citing works

Update on bipolar disorder biomarker candidates: what about uric acid/adenosine hypothesis?

Bartoli, F., Carrà, G., & Clerici, M. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1270757 · Cited by 9 · see citing works

Not All Inflammatory Biomarkers Are Elevated in Bipolar Disorder: Evidence for Procalcitonin

Barbosa, I. G., Rocha, N. P., Filho, L. H. P., Oliveira, C., Junior, V. A. N., & Teixeira, A. L. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.010 · Cited by 8 · see citing works

Comparación de biomarcadores inflamatorios en pacientes con trastorno afectivo bipolar tipo I y sujetos controles

Palacio, J. D., Guzman, S., Vargas, C., Díaz‐Zuluaga, A. M., & López‐Jaramillo, C. (2015) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2015.06.002 · Cited by 6 · see citing works

Exploring Clinical Subgroups of Participants with Major Depressive Disorder that may Benefit from Adjunctive Minocycline Treatment

Anmella, G., Meehan, A., Ashton, M. M., Mohebbi, M., Fico, G., Ng, C. H., Maes, M. H. J., Berk, L., Prisco, M. D., Singh, A., et al. (2023) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.23.1098 · Cited by 5 · see citing works

The conundrum of the connection between severe psychiatric disorders and dementia

Teixeira, A. L., de Erausquin, G. A., & Olvera, R. L. (2025) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2024-0223 · Cited by 4 · see citing works

Neuroprogression in bipolar disorder

Tusconi, M., & Fries, G. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821398-8.00009-6 · Cited by 4 · see citing works

The effect of the number of psychiatric hospitalizations and diagnosis in serum levels of CCL11 and GDF15 in individuals with stable schizophrenia, bipolar disorder, and major depressive disorder: The compass between neuro and somatoprogression

Costanzi, M., Goularte, J. F., Silva, L. R., Siebert, M., de Carvalho, I. D. M., Ziani, P. R., Deckmann, I., Santos‐Terra, J., Gottfried, C., Fleck, M. P. D. A., et al. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111446 · Cited by 3 · see citing works

Additional file 1: of Differential mitochondrial DNA copy number in three mood states of bipolar disorder

Wang, D., Li, Z., Liu, W., Zhou, J., Ma, X., Tang, J., & Chen, X. (2018) · Figshare · doi:10.6084/m9.figshare.6362948

Differential mitochondrial DNA copy number in three mood states of bipolar disorder

Wang, D., Li, Z., Liu, W., Zhou, J., Ma, X., Tang, J., & Chen, X. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1717-8 · Cited by 60 · see citing works

Low peripheral mitochondrial DNA copy number during manic episodes of bipolar disorders is associated with disease severity and inflammation

Angrand, L., Boukouaci, W., Lajnef, M., Richard, J., Andreazza, A. C., Wu, C.-L., Bouassida, J., Rafik, I., Foiselle, M., Mezouad, E., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.09.003 · Cited by 37 · see citing works

Mitochondrial DNA copy number is significantly increased in bipolar disorder patients and is correlated with long-term lithium treatment

Meloni, A., Paribello, P., Pinna, M., Contu, M., Ardau, R., Chillotti, C., Congiu, D., Gennarelli, M., Minelli, A., Buson, L., et al. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.10.012 · Cited by 9 · see citing works

Differences in mitochondrial DNA copy number between patients with bipolar I and II disorders

Chung, J. K., Ahn, Y. M., Kim, S. A., & Joo, E.-J. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.11.016 · Cited by 23 · see citing works